دورية أكاديمية

Effects of short-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia

التفاصيل البيبلوغرافية
العنوان: Effects of short-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia
المؤلفون: de Divitiis, M, Di Somma, S, Montefusco, S, Carreras, G, Greco, V, Carotenuto, A, de Divitiis, O., RUBBA, PAOLO OSVALDO FEDERICO, LIGUORI, VINCENZO, GALDERISI, MAURIZIO, IANNUZZO, GABRIELLA
المساهمون: de Divitiis, M, Rubba, PAOLO OSVALDO FEDERICO, Di Somma, S, Liguori, Vincenzo, Galderisi, Maurizio, Montefusco, S, Carreras, G, Greco, V, Carotenuto, A, Iannuzzo, Gabriella, de Divitiis, O.
سنة النشر: 1996
المجموعة: IRIS Università degli Studi di Napoli Federico II
مصطلحات موضوعية: Analysis of Variance, Angina Pectori, Anticholesteremic Agent, Cholesterol, LDL, Electrocardiography, Exercise Test, Forearm, Human, Hypercholesterolemia, Lovastatin, Middle Aged, Regional Blood Flow, Simvastatin, Single-Blind Method
الوصف: To evaluate the effects of short-term cholesterol-lowering treatment on myocardial effort ischemia, 22 patients with stable effort ischemia and mild to moderate hypercholesterolemia (low density lipoprotein [LDL] cholesterol 160 to 220 mg/dl) were randomly allocated at baseline (TO) in 2 groups. Group A included 12 patients treated with simvastatin 10 mg bid; group B included 10 patients treated with placebo. All patients underwent a treadmill electrocardiography (ECG) test; total cholesterol, HDL and LDL cholesterol, triglycerides, plasma, and blood viscosity were measured. All tests were repeated after 4 and 12 weeks. For 18 of the same patients (11 taking simvastatin, 7 receiving placebo), forearm strain-gouge plethysmography was performed at baseline and after 4 weeks, both at rest and during reactive hyperemia. At 4 and 12 weeks, group A showed a significant reduction in total cholesterol (p <0.05) and LDL (p <0.05), with unchanged HDL, triglycerides, blood, and plasma viscosity. Effort was unmodified, ST-segment depression at peak effort and ischemic threshold were significantly improved after 4 and 12 weeks (all p <0.05) with unchanged heart rate x systolic blood pressure product. A significant increase in the excess flow response to reactive hyperemia was detected in group A (p <0.03); group B showed no changes in hematochemical and ergometric parameters. These data suggest that cholesterol-lowering treatment is associated with an improvement in myocardial effort ischemia; this might be explained by a more pronounced increase of coronary blood flow and capacity of vasodilation in response to effort.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: volume:78; issue:7; firstpage:763-8; journal:THE AMERICAN JOURNAL OF CARDIOLOGY; http://hdl.handle.net/11588/645952Test
الإتاحة: http://hdl.handle.net/11588/645952Test
رقم الانضمام: edsbas.80277599
قاعدة البيانات: BASE